Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment
Xueru Mu, … , Isabelle A. Leclercq, Robert F. Schwabe
Xueru Mu, … , Isabelle A. Leclercq, Robert F. Schwabe
Published September 8, 2015
Citation Information: J Clin Invest. 2015;125(10):3891-3903. https://doi.org/10.1172/JCI77995.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 4

Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment

  • Text
  • PDF
Abstract

In many organs, including the intestine and skin, cancers originate from cells of the stem or progenitor compartment. Despite its nomenclature, the cellular origin of hepatocellular carcinoma (HCC) remains elusive. In contrast to most organs, the liver lacks a defined stem cell population for organ maintenance. Previous studies suggest that both hepatocytes and facultative progenitor cells within the biliary compartment are capable of generating HCC. As HCCs with a progenitor signature carry a worse prognosis, understanding the origin of HCC is of clinical relevance. Here, we used complementary fate-tracing approaches to label the progenitor/biliary compartment and hepatocytes in murine hepatocarcinogenesis. In genotoxic and genetic models, HCCs arose exclusively from hepatocytes but never from the progenitor/biliary compartment. Cytokeratin 19–, A6- and α-fetoprotein–positive cells within tumors were hepatocyte derived. In summary, hepatocytes represent the cell of origin for HCC in mice, and a progenitor signature does not reflect progenitor origin, but dedifferentiation of hepatocyte-derived tumor cells.

Authors

Xueru Mu, Regina Español-Suñer, Ingmar Mederacke, Silvia Affò, Rita Manco, Christine Sempoux, Frédéric P. Lemaigre, Arlind Adili, Detian Yuan, Achim Weber, Kristian Unger, Mathias Heikenwälder, Isabelle A. Leclercq, Robert F. Schwabe

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 Total
Citations: 1 5 11 10 14 19 13 13 14 7 1 108
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (108)

Title and authors Publication Year
Folliculin depletion results in liver cell damage and cholangiocarcinoma through MiT/TFE activation.
Custode BM, Annunziata F, Dos Santos Matos F, Schiano V, Maffia V, Lillo M, Colonna R, De Cegli R, Ballabio A, Pastore N
Cell death and differentiation 2025
Initiation of Cancer: The Journey From Mutations in Somatic Cells to Epigenetic Changes in Tissue-resident VSELs.
Bhartiya D, Raouf S, Pansare K, Tripathi A, Tripathi A
Stem Cell Reviews and Reports 2024
Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.
Ma Y, Lv H, Xing F, Xiang W, Wu Z, Feng Q, Wang H, Yang W
Frontiers of Medicine 2024
Single‐cell multi‐modal chromatin profiles revealing epigenetic regulations of cells in hepatocellular carcinoma
Wang C, Huang W, Zhong Y, Zou X, Liu S, Li J, Sun Y, Zhou K, Chen X, Li Z, Wang S, Huang Y, Bai Y, Yin J, Jin X, Liu S, Yuan Y, Deng Q, Jiang M, Liu C, Liu L, Xu X, Wu L
Clinical and Translational Medicine 2024
Aberrant differentiation and proliferation of hepatocytes in chronic liver injury and liver tumors.
Nishikawa Y
Pathology international 2024
Current status and new directions for hepatocellular carcinoma diagnosis
Tu J, Wang B, Wang X, Huo K, Hu W, Zhang R, Li J, Zhu S, Liang Q, Han S
Liver Research 2024
Monocyte-derived macrophages orchestrate multiple cell types to repair necrotic liver lesions
Dechun Feng, Xiaogang Xiang, Yukun Guan, Adrien Guillot, Hongkun Lu, Chingwen Chang, Yong He, Hua Wang, Hongna Pan, Cynthia Ju, Sean Colgan, Frank Tacke, XinWei Wang, George Kunos, Bin Gao
Journal of Clinical Investigation 2023
Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination
Gromowski T, Lukacs-Kornek V, Cisowski J
Cancer Cell International 2023
Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma
Hu X, Wang Q, Huang G, He X, Sparrelid E, Brismar TB, Fan Y
Computational and mathematical methods in medicine 2023
Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease
van Son KC, Verschuren L, Hanemaaijer R, Reeves H, Takkenberg RB, Drenth JP, Tushuizen ME, Holleboom AG
Cancers 2023
The Role of the Ectopeptidase APN/CD13 in Cancer
Lendeckel U, Karimi F, Al Abdulla R, Wolke C
Biomedicines 2023
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Kouroumalis E, Tsomidis I, Voumvouraki A
Biomedicines 2023
Single-nucleus RNA sequencing of pre-malignant liver reveals disease-associated hepatocyte state with HCC prognostic potential
Carlessi R, Denisenko E, Boslem E, Köhn-Gaone J, Main N, Abu Bakar ND, Shirolkar GD, Jones M, Beasley AB, Poppe D, Dwyer BJ, Jackaman C, Tjiam MC, Lister R, Karin M, Fallowfield JA, Kendall TJ, Forbes SJ, Gray ES, Olynyk JK, Yeoh G, Forrest AR, Ramm GA, Febbraio MA, Tirnitz-Parker JE
2023
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid
Qin XY, Furutani Y, Yonezawa K, Shimizu N, Kato-Murayama M, Shirouzu M, Xu Y, Yamano Y, Wada A, Gailhouste L, Shrestha R, Takahashi M, Keillor JW, Su T, Yu W, Fujii S, Kagechika H, Dohmae N, Shirakami Y, Shimizu M, Masaki T, Matsuura T, Suzuki H, Kojima S
Cell Death and Disease 2023
A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d
Domènech Omella J, Cortesi EE, Verbinnen I, Remmerie M, Wu H, Cubero FJ, Roskams T, Janssens V
Cancers 2023
Chronic metabolic stress drives developmental programs and loss of tissue functions in non-transformed liver that mirror tumor states and stratify survival
Tzouanas CN, Sherman MS, Shay JE, Rubin AJ, Mead BE, Dao TT, Butzlaff T, Mana MD, Kolb KE, Walesky C, Pepe-Mooney BJ, Smith CJ, Prakadan SM, Ramseier ML, Tong EY, Joung J, Chi F, McMahon-Skates T, Winston CL, Jeong WJ, Aney KJ, Chen E, Nissim S, Zhang F, Deshpande V, Lauer GM, Yilmaz ÖH, Goessling W, Shalek AK
2023
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Ye L, Schneider JS, Ben Khaled N, Schirmacher P, Seifert C, Frey L, He Y, Geier A, De Toni EN, Zhang C, Reiter FP
Liver Cancer 2023
Liver is a primary source of insulin-like growth factor-1 in skin wound healing
R Roberts, J Cavalcante-Silva, R Kineman, T Koh
Journal of Endocrinology 2022
Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances
B Cucarull, A Tutusaus, P Rider, T Hernáez-Alsina, C Cuño, P de Frutos, A Colell, M Marí, A Morales
Cancers 2022
Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds
H Mai, H Xie, M Luo, J Hou, J Chen, J Hou, D Jiang
Cancers 2022
Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis
Y Liu, S Zhuo, Y Zhou, L Ma, Z Sun, X Wu, X Wang, B Gao, Y Yang
Journal of Hepatology 2022
Cellular origins of regenerating liver and hepatocellular carcinoma
Á Holczbauer, K Wangensteen, S Shin
2022
Opposing roles of HDAC6 in liver regeneration and hepatocarcinogenesis
Phorl S, Memon A, Seo Y, Hoang TO, Tran TN, Nguyen LM, Lee CH, Lee WK, Lee J
Cancer Science 2022
Rare Inherited Cholestatic Disorders and Molecular Links to Hepatocarcinogenesis
Jeyaraj R, Kelly D
Cells 2022
Clinical applications of circulating tumor cells in hepatocellular carcinoma
Hua Y, Dong J, Hong J, Wang B, Yan Y, Li Z
Frontiers in Oncology 2022
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis.
Filliol A, Saito Y, Nair A, Dapito DH, Yu LX, Ravichandra A, Bhattacharjee S, Affo S, Fujiwara N, Su H, Sun Q, Savage TM, Wilson-Kanamori JR, Caviglia JM, Chin L, Chen D, Wang X, Caruso S, Kang JK, Amin AD, Wallace S, Dobie R, Yin D, Rodriguez-Fiallos OM, Yin C, Mehal A, Izar B, Friedman RA, Wells RG, Pajvani UB, Hoshida Y, Remotti HE, Arpaia N, Zucman-Rossi J, Karin M, Henderson NC, Tabas I, Schwabe RF
Nature 2022
Redox-Regulation in Cancer Stem Cells.
Lendeckel U, Wolke C
Biomedicines 2022
Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver
VJ Barthet, M Brucoli, MJ Ladds, C Nössing, C Kiourtis, AD Baudot, J OPrey, B Zunino, M Müller, S May, C Nixon, JS Long, TG Bird, KM Ryan
Science Advances 2021
Hyperpolyploidization of hepatocyte initiates preneoplastic lesion formation in the liver
H Lin, YS Huang, JM Fustin, M Doi, H Chen, HH Lai, SH Lin, YL Lee, PC King, HS Hou, HW Chen, PY Young, HW Chao
Nature Communications 2021
The immunological and metabolic landscape in primary and metastatic liver cancer
X Li, P Ramadori, D Pfister, M Seehawer, L Zender, M Heikenwalder
Nature Reviews Cancer 2021
Cell of origin in biliary tract cancers and clinical implications
A Moeini, PK Haber, D Sia
2021
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
TK Lee, XY Guan, S Ma
Nature Reviews Gastroenterology & Hepatology 2021
Dietary and Genetic Cholesterol Loading Rather Than Steatosis Promotes Liver Tumorigenesis and NASH-Driven HCC
V Ribas, LC de la Rosa, D Robles, S Núñez, P Segalés, N Insausti-Urkia, E Solsona-Vilarrasa, J Fernández-Checa, C García-Ruiz
Cancers 2021
Ssu72-HNF4α signaling axis classify the transition from steatohepatitis to hepatocellular carcinoma
HS Kim, JS Yoon, Y Jeon, EJ Park, JK Lee, S Chen, H Lee, JY Park, H Go, CW Lee
Cell Death and Differentiation 2021
Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis
S Kurosaki, H Nakagawa, Y Hayata, S Kawamura, Y Matsushita, T Yamada, K Uchino, Y Hayakawa, N Suzuki, M Hata, M Tsuboi, H Kinoshita, Y Tanaka, T Nakatsuka, Y Hirata, K Tateishi, K Koike
2021
Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice
J Baglieri, C Zhang, S Liang, X Liu, T Nishio, SB Rosenthal, D Dhar, H Su, M Cong, J Jia, M Hosseini, M Karin, T Kisseleva, DA Brenner
The American Journal of Pathology 2021
Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches
Z Farzaneh, M Vosough, T Agarwal, M Farzaneh
Cancer Cell International 2021
Non-Genomic Control of Dynamic MYCN Gene Expression in Liver Cancer
XY Qin, L Gailhouste
Frontiers in Oncology 2021
Nuclear VEGFR-2 Expression of Hepatocytes Is Involved in Hepatocyte Proliferation and Liver Regeneration During Chronic Liver Injury
AR Lee, SM Baek, SW Lee, TU Kim, JE Han, S Bae, SJ Park, TH Kim, KS Jeong, SK Choi, JK Park
In vivo (Athens, Greece) 2021
Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis
LA Broadfield, JA Duarte, R Schmieder, D Broekaert, K Veys, M Planque, K Vriens, Y Karasawa, F Napolitano, S Fujita, M Fujii, M Eto, B Holvoet, R Vangoitsenhoven, J Fernandez-Garcia, JV Elsen, J Dehairs, J Zeng, J Dooley, RA Rubio, J van Pelt, TG Grünewald, A Liston, C Mathieu, CM Deroose, JV Swinnen, D Lambrechts, D di Bernardo, S Kuroda, KD Bock, SM Fendt
Cancer research 2021
Targeting the De Novo Purine Synthesis Pathway Through Adenylosuccinate Lyase Depletion Impairs Liver Cancer Growth by Perturbing Mitochondrial Function
T Jiang, FJ SánchezRivera, YM SotoFeliciano, Q Yang, CQ Song, A Bhuatkar, CM Haynes, MT Hemann, W Xue
Hepatology 2021
The Cancer Stem Cell in Hepatocellular Carcinoma
LA Schulte, JC López-Gil, B Sainz, PC Hermann
Cancers 2020
Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features
X Cai, H Li, DE Kaplan
Cell & Bioscience 2020
FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome
F Li, P Huangyang, M Burrows, K Guo, R Riscal, J Godfrey, KE Lee, N Lin, P Lee, IA Blair, B Keith, B Li, MC Simon
Nature Cell Biology 2020
The HMGB1-RAGE axis modulates the growth of autophagy-deficient hepatic tumors
B Khambu, H Hong, S Liu, G Liu, X Chen, Z Dong, J Wan, XM Yin
Cell Death and Disease 2020
Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanism
N Ali, CB Nguyen, P Chandrakesan, RF Wolf, D Qu, R May, T Goretsky, J Fazili, TA Barrett, M Li, MM Huycke, MS Bronze, CW Houchen
Scientific Reports 2020
Liver Progenitors and Adult Cell Plasticity in Hepatic Injury and Repair: Knowns and Unknowns
S Ko, JO Russell, LM Molina, SP Monga
Annual review of pathology 2020
Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
L Walcher, AK Kistenmacher, H Suo, R Kitte, S Dluczek, A Strauß, AR Blaudszun, T Yevsa, S Fricke, U Kossatz-Boehlert
Frontiers in immunology 2020
The cellular origins of cancer with particular reference to the gastrointestinal tract
MR Alison
International Journal of Experimental Pathology 2020
Loss of SRSF2 triggers hepatic progenitor cell activation and tumor development in mice
C Zhang, L Shen, W Yuan, Y Liu, R Guo, Y Luo, Z Zhan, Z Xie, G Wu, W Wu, Y Feng
2020
Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features
C Zhu, YJ Ho, MA Salomao, DH Dapito, A Bartolome, RF Schwabe, JS Lee, SW Lowe, UB Pajvani
Journal of Hepatology 2020
Fate and functional roles of Prominin 1+ cells in liver injury and cancer
R Wu, S Pan, Y Chen, Y Nakano, M Li, S Balog, H Tsukamoto
Scientific Reports 2020
Oncogenic driver genes and tumor microenvironment determine the type of liver cancer
G Wang, Q Wang, N Liang, H Xue, T Yang, X Chen, Z Qiu, C Zeng, T Sun, W Yuan, C Liu, Z Chen, X He
Cell Death and Disease 2020
Somatic mutation landscape reveals differential variability of cell-of-origin for primary liver cancer
K Ha, M Fujita, R Karlić, S Yang, R Xue, C Zhang, F Bai, N Zhang, Y Hoshida, P Polak, H Nakagawa, HG Kim, H Lee
Heliyon 2020
CK19-positive Hepatocellular Carcinoma is a Characteristic Subtype
JY Zhuo, D Lu, WY Tan, SS Zheng, YQ Shen, X Xu
Journal of Cancer 2020
Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression
H Rhee, H Kim, YN Park
Liver Cancer 2020
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis
C Orrù, A Perra, MA Kowalik, S Rizzolio, E Puliga, L Cabras, S Giordano, A Columbano
Cancers 2020
Adeno-Associated Virus Serotype 8-Mediated Genetic Labeling of Cholangiocytes in the Neonatal Murine Liver
S Lee, P Zhou, S Whyte, S Shin
Pharmaceutics 2020
Predicting miRNA targets for hepatocellular carcinoma with an integrated method
Y Shi, T Wen, D Xiao, L Dai, J Song
Translational cancer research 2020
Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Tumors Following Chronic Liver Injury
Y Lin, S Zhang, M Zhu, T Lu, K Chen, Z Wen, S Wang, G Xiao, D Luo, Y Jia, L Li, M MacConmara, Y Hoshida, A Singal, A Yopp, T Wang, H Zhu
Gastroenterology 2020
Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice
L Zong, H Peng, C Sun, F Li, M Zheng, Y Chen, H Wei, R Sun, Z Tian
Nature Communications 2019
Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis
SK Kim, H Takeda, A Takai, T Matsumoto, N Kakiuchi, A Yokoyama, K Yoshida, T Kaido, S Uemoto, S Minamiguchi, H Haga, Y Shiraishi, S Miyano, H Seno, S Ogawa, H Marusawa
Journal of Gastroenterology 2019
Comparison of the Opn-CreER and Ck19-CreER Drivers in Bile Ducts of Normal and Injured Mouse Livers
Lesaffer, Verboven, V Huffel, Moya, van Grunsven, Leclercq, Lemaigre, Halder
Cells 2019
The Molecular Chaperone Heat Shock Protein 70 Controls Liver Cancer Initiation and Progression by Regulating Adaptive DNA Damage and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling Pathways
W Cho, X Jin, J Pang, Y Wang, NF Mivechi, D Moskophidis
Molecular and cellular biology 2019
The evolving landscape of precision medicine in primary liver cancer
SP Martin, XW Wang
Hepatic Oncology 2019
HDAC3 deficiency promotes liver cancer through a defect in H3K9ac/H3K9me3 transition
H Ji, Y Zhou, X Zhuang, Y Zhu, Z Wu, Y Lu, S Li, Y Zeng, QR Lu, Y Huo, Y Shi, H Bu
Cancer research 2019
Hepatic Cellular Distribution of Silica Nanoparticles by Surface Energy Modification
AR Lee, K Nam, BJ Lee, SW Lee, SM Baek, JS Bang, SK Choi, SJ Park, TH Kim, KS Jeong, DY Lee, JK Park
International journal of molecular sciences 2019
IGF2 mRNA Binding Protein 2 Transgenic Mice Are More Prone to Develop a Ductular Reaction and to Progress Toward Cirrhosis
B Czepukojc, A Abuhaliema, A Barghash, S Tierling, N Naß, Y Simon, C Körbel, C Cadenas, N van Hul, A Sachinidis, JG Hengstler, V Helms, MW Laschke, J Walter, J Haybaeck, I Leclercq, AK Kiemer, SM Kessler
Frontiers in Medicine 2019
Lgr5 + pericentral hepatocytes are self-maintained in normal liver regeneration and susceptible to hepatocarcinogenesis
CH Ang, SH Hsu, F Guo, CT Tan, VC Yu, JE Visvader, PK Chow, NY Fu
Proceedings of the National Academy of Sciences 2019
SIRT1 in the Development and Treatment of Hepatocellular Carcinoma
M Farcas, AA Gavrea, D Gulei, C Ionescu, A Irimie, CS Catana, I Berindan-Neagoe
Frontiers in Nutrition 2019
Cell Biology and Translational Medicine, Volume 7: Stem Cells and Therapy: Emerging Approaches
K Turksen
2019
Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cells
Z Dai, G Song, A Balakrishnan, T Yang, Q Yuan, S Möbus, AC Weiss, M Bentler, J Zhu, X Jiang, X Shen, H Bantel, E Jaeckel, A Kispert, A Vogel, A Saborowski, H Büning, M Manns, T Cantz, M Ott, AD Sharma
Gut 2019
Kinetic modelling of quantitative proteome data predicts metabolic reprogramming of liver cancer
N Berndt, A Egners, G Mastrobuoni, O Vvedenskaya, A Fragoulis, A Dugourd, S Bulik, M Pietzke, C Bielow, R van Gassel, SW Damink, M Erdem, J Saez-Rodriguez, HG Holzhütter, S Kempa, T Cramer
British Journal of Cancer 2019
HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis
Céline Hernandez, Peter Huebener, Jean-Philippe Pradere, Daniel Antoine, Richard A Friedman, Robert Schwabe
Journal of Clinical Investigation 2018
HMGB1 Promotes Ductular Reaction and Tumorigenesis in Autophagy-deficient Livers
Bilon Khambu, Nazmul Huda, Xiaoyun Chen, Daniel Antoine, Yong Li, Guoli Dai, Ulrike Kohler, Wei-Xing Zong, Satoshi Waguri, Sabine Werner, Tim Oury, Zheng Dong, Xiao-Ming Yin
Journal of Clinical Investigation 2018
Hypercholesterolemia induces T cell expansion in humanized immune mice
Jonathan D Proto, Amanda Doran, Manikandan Subramanian, Hui Wang, Mingyou Zhang, Erdi Sozen, Christina Rymond, George Kuriakose, Vivette D'Agati, Robert Winchester, Megan Sykes, Yong-Guang Yang, Ira Tabas
Journal of Clinical Investigation 2018
Animal models to study bile acid metabolism
J Li, PA Dawson
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
DS Ghorpade, L Ozcan, Z Zheng, SM Nicoloro, Y Shen, E Chen, M Blüher, MP Czech, I Tabas
Nature 2018
Differentiation-inducing therapeutic effect of Notch inhibition in reversing malignant transformation of liver normal stem cells via MET
H Luo, W Liu, H Liang, H Yan, N Lin, D Li, T Wang, L Tang
Oncotarget 2018
Animal models of biliary injury and altered bile acid metabolism
V Mariotti, M Strazzabosco, L Fabris, DF Calvisi
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018
CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance
M Xu, S Fang, J Song, M Chen, Q Zhang, Q Weng, X Fan, W Chen, X Wu, F Wu, J Tu, Z Zhao, J Ji
Cell Death and Disease 2018
Liver Regeneration: Different Sub-Populations of Parenchymal Cells at Play Choreographed by an Injury-Specific Microenvironment
R Manco, IA Leclercq, LA Clerbaux
International journal of molecular sciences 2018
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
C Zhu, KJ Kim, X Wang, A Bartolome, M Salomao, P Dongiovanni, M Meroni, MJ Graham, KP Yates, AM Diehl, RF Schwabe, I Tabas, L Valenti, JE Lavine, UB Pajvani
Science Translational Medicine 2018
Pregnane X Receptor Regulates Liver Size and Liver Cell Fate by Yes-Associated Protein Activation in Mice: HEPATOLOGY
Y Jiang, D Feng, X Ma, S Fan, Y Gao, K Fu, Y Wang, J Sun, X Yao, C Liu, H Zhang, L Xu, A Liu, FJ Gonzalez, Y Yang, B Gao, M Huang, H Bi
Hepatology 2018
An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1
Z Zheng, L Nayak, W Wang, A Yurdagul, X Wang, B Cai, S Lapping, L Ozcan, R Ramakrishnan, RG Pestell, MK Jain, I Tabas
Blood 2018
Liver and Pancreas: Do Similar Embryonic Development and Tissue Organization Lead to Similar Mechanisms of Tumorigenesis?
E Ghurburrun, I Borbath, FP Lemaigre, P Jacquemin
Gene expression 2018
The Role of Cancer-Associated Fibroblasts and Fibrosisin Liver Cancer
S Affo, LX Yu, RF Schwabe
Annual review of pathology 2017
Hepatocyte-specific Smad7 deletion accelerates DEN-induced HCC via activation of STAT3 signaling in mice
T Feng, J Dzieran, X Yuan, A Dropmann, T Maass, A Teufel, S Marhenke, T Gaiser, F Rückert, I Kleiter, S Kanzler, MP Ebert, A Vogel, P Dijke, S Dooley, NM Meindl-Beinker
Oncogenesis 2017
Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis
JE Yoo, YJ Kim, H Rhee, H Kim, EY Ahn, JS Choi, M Roncalli, YN Park, T Yamashita
PloS one 2017
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells
KS Tummala, M Brandt, A Teijeiro, O Graña, RF Schwabe, C Perna, N Djouder
Cell Reports 2017
Road to stemness in hepatocellular carcinoma
TN Flores-Téllez, S Villa-Treviño, C Piña-Vázquez
World journal of gastroenterology : WJG 2017
Loss of liver-specific and sexually dimorphic gene expression by aryl hydrocarbon receptor activation in C57BL/6 mice
R Nault, KA Fader, JR Harkema, T Zacharewski, H Guillou
PloS one 2017
Global Analysis of Plasma Lipids Identifies Liver-Derived Acylcarnitines as a Fuel Source for Brown Fat Thermogenesis
J Simcox, G Geoghegan, JA Maschek, CL Bensard, M Pasquali, R Miao, S Lee, L Jiang, I Huck, EE Kershaw, AJ Donato, U Apte, N Longo, J Rutter, R Schreiber, R Zechner, J Cox, CJ Villanueva
Cell Metabolism 2017
The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
O Govaere, M Petz, J Wouters, YP Vandewynckel, EJ Scott, B Topal, F Nevens, C Verslype, QM Anstee, HV Vlierberghe, W Mikulits, T Roskams
Oncogene 2017
TET-Catalyzed 5-Hydroxymethylation Precedes HNF4A Promoter Choice during Differentiation of Bipotent Liver Progenitors
PB Ancey, S Ecsedi, MP Lambert, FR Talukdar, MP Cros, D Glaise, DM Narvaez, V Chauvet, Z Herceg, A Corlu, H Hernandez-Vargas
Stem Cell Reports 2017
Hepatocyte selection medium-enriched hepatocellular carcinoma cells are positive for α-fetoprotein and CD44
M Tomizawa, F Shinozaki, Y Motoyoshi, T Sugiyama, S Yamamoto, N Ishige
Oncology Letters 2017
FOXA2 alleviates CCl4-induced liver fibrosis by protecting hepatocytes in mice
W Wang, LJ Yao, W Shen, K Ding, PM Shi, F Chen, J He, J Ding, X Zhang, WF Xie
Scientific Reports 2017
Fate tracing of hepatocytes in mouse liver
X Gu, D Huang, L Ci, J Shi, M Zhang, H Yang, Z Wang, Z Sheng, R Sun, J Fei
Scientific Reports 2017
Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration
S Zhang, LH Nguyen, K Zhou, HC Tu, A Sehgal, I Nassour, L Li, P Gopal, J Goodman, AG Singal, A Yopp, Y Zhang, DJ Siegwart, H Zhu
Gastroenterology 2017
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.
Castelli G, Pelosi E, Testa U
Cancers 2017
Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+- liver cells deficient for p53 and Rb
RB Matondo, MJ Toussaint, KM Govaert, LD van Vuuren, S Nantasanti, MW Nijkamp, SK Pandit, PC Tooten, MH Koster, K Holleman, A Schot, G Gu, B Spee, T Roskams, IB Rinkes, B Schotanus, O Kranenburg, A Bruin
Oncotarget 2016
Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice
S Shin, KJ Wangensteen, M Teta-Bissett, YJ Wang, E Mosleh-Shirazi, EL Buza, LE Greenbaum, KH Kaestner
Hepatology 2016
Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population
T Duarte-Salles, S Misra, M Stepien, A Plymoth, D Muller, K Overvad, A Olsen, A Tjonneland, L Baglietto, G Severi, MC Boutron-Ruault, R Turzanski-Fortner, R Kaaks, H Boeing, K Aleksandrova, A Trichopoulou, P Lagiou, C Bamia, V Pala, D Palli, A Mattiello, R Tumino, A Naccarati, HB Bueno-de-Mesquita, PH Peeters, E Weiderpass, JR Quiros, A Agudo, E Sanchez-Cantalejo, E Ardanaz, D Gavrila, M Dorronsoro, M Werner, O Hemmingsson, B Ohlsson, K Sjo berg, NJ Wareham, KT Khaw, KE Bradbury, MJ Gunter, AJ Cross, E Riboli, M Jenab, P Hainaut, L Beretta
Cancer prevention research (Philadelphia, Pa.) 2016
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
X Wang, Z Zheng, JM Caviglia, KE Corey, TM Herfel, B Cai, R Masia, RT Chung, JH Lefkowitch, RF Schwabe, I Tabas
Cell Metabolism 2016
Differentiation and Inflammation: ‘Best Enemies’ in Gastrointestinal Carcinogenesis
NM Krah, LC Murtaugh
Trends in Cancer 2016
Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis
Eliene Bogaerts, Annelies Paridaens, Xavier Verhelst, Peter Carmeliet, Anja Geerts, Hans Van Vlierberghe, Lindsey Devisscher
EXCLI J 2016
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Sia D, Villanueva A, Friedman SL, Llovet JM
Gastroenterology 2016
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
Posted by 1 X users
On 1 Facebook pages
202 readers on Mendeley
See more details